MEETINGS - Protecting Biotechnological Inventions (Belgium) September 1998:
This article was originally published in Clinica
Executive Summary
IBC Conferences will hold a meeting on Protecting Biotechnological Inventions on September 17-18 in Brussels. Discussion will focus on biotech patent drafting considerations in various countries including Japan and Australia; the impact of the EU biotech directive on the European Patent Office (EPO); latest practice developments at the EPO; implications of the biosafety protocol for commerce and research; and issues of enablement and definitiveness in the US. For more information contact IBC's UK office. Tel: +44 171 453 5492. Fax: +44 171 636 6858.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.